The annual gathering exploring the inherently complex and continually contentious pharma and biotech patent litigation

Life Science patent litigation filings are predicted to rise at new levels. Be part of the only event where the “Who’s Who” of the European Life Sciences Patent Bar gather each year to shape the patent litigation policies and procedures throughout the continent. The Pharmaceutical and Biotechnology industries are becoming increasingly competitive in the IP sphere. There will inevitably be areas where overlapping, interference, and marketing coming into play. However, the ability to secure and capitalize on the investment in patent rights and IP protections will mean a greater economic return for your products as well as IP portfolio. C5’s 11th Annual Pharma and Biotech Patent Litigation Forum comes at a significant time in Europe. With Brexit looming and the impending ratification of UPC from the German national courts, there are plenty of uncertainties for Pharmaceutical and Biotech companies conducting business in the European Market. This event is where you will find clarification on such matters and their consequential impact on patent litigation strategies.

Key Themes for 2019

  • The Impact of Brexit on the UPC
  • The Trade Secret Directive’s effect on patent rights
  • The repercussions of recent Court of Justice SPC rulings
  • Digital concerns for the quality of patents
  • Functional patent claims and related burden of proof analyses

International IP Focus Sessions on:

  • U.S.: IP actions in the District Courts and the PTO’s PTAB
  • Asia: The impact of China IP on international IP

Find out more about the conference, agenda, speakers and hot topics…

DOWNLOAD THE FULL BROCHURE

This Pan-European Pharma and Biotech Patent Litigation Forum will Feature Insights and Practical Guidance from:

Adrian Spillmann Head of Corporate IP Valneva
Dr. Stephan Kutik European Patent Attorney Chiesi Farmaceutici S.P.A
Francesco Macchetta Director Intellectual Property Bracco Group
Dr. Lorenz Kallenbach Corporate Patent Counsel Merck Group
Dean Thomas Head of Intellectual Property Glenmark Pharmaceuticals
Hubert Witte Head of Patents Roche

This is your once-a-year opportunity to brainstorm and network with General Counsel and Head of IP from leading Pharmaceutical and Biotech companies.

Join us at this exciting time of change and planning your future Patent Litigation strategy!

REGISTER NOW

THIS IS A MUST ATTEND EVENT FOR:

  • VP Intellectual Property
  • Patent Attorney
  • IP Director
  • Chief IP Counsel
  • Head of Legal
  • General Counsel
  • IP Director
  • IP and Business Strategy
  • Principal Patent Attorney
  • Vice President
  • Global IP & Litigation
  • Managing Counsel
  • European Patents Partner
  • Patent Attorney
  • IP Specialist

OUR PRIOR DELEGATES SAY IT BEST:

“The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.”

Dr. Andreas Geissler, LEUKOCARE AG

“Good networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.”

Anna Lopez Lozano, ESTEVE QUÍMICA

“Important subject matters to discuss presented by renowned specialists. An important conference to attend.”

Manuel Duraes Rocha, ABREU ADVOGADOS